These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35406726)

  • 1. Src-Family Protein Kinase Inhibitors Suppress MYB Activity in a p300-Dependent Manner.
    Biyanee A; Yusenko MV; Klempnauer KH
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibitors suppress MYB oncogenic activity in a p300-dependent manner.
    Yusenko MV; Biyanee A; Andersson MK; Radetzki S; von Kries JP; Stenman G; Klempnauer KH
    Cancer Lett; 2021 Nov; 520():132-142. PubMed ID: 34256093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells.
    Yusenko MV; Trentmann A; Andersson MK; Ghani LA; Jakobs A; Arteaga Paz MF; Mikesch JH; Peter von Kries J; Stenman G; Klempnauer KH
    Cancer Lett; 2020 Jun; 479():61-70. PubMed ID: 32014461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-Molecule Disruption of the Myb/p300 Cooperation Targets Acute Myeloid Leukemia Cells.
    Uttarkar S; Piontek T; Dukare S; Schomburg C; Schlenke P; Berdel WE; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Mol Cancer Ther; 2016 Dec; 15(12):2905-2915. PubMed ID: 27707899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction.
    Uttarkar S; Dassé E; Coulibaly A; Steinmann S; Jakobs A; Schomburg C; Trentmann A; Jose J; Schlenke P; Berdel WE; Schmidt TJ; Müller-Tidow C; Frampton J; Klempnauer KH
    Blood; 2016 Mar; 127(9):1173-82. PubMed ID: 26631113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression.
    Coulibaly A; Haas A; Steinmann S; Jakobs A; Schmidt TJ; Klempnauer KH
    PLoS One; 2018; 13(2):e0190934. PubMed ID: 29394256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia.
    Yusenko MV; Trentmann A; Casolari DA; Abdel Ghani L; Lenz M; Horn M; Dörner W; Klempnauer S; Mootz HD; Arteaga MF; Mikesch JH; D'Andrea RJ; Gonda TJ; Müller-Tidow C; Schmidt TJ; Klempnauer KH
    Oncogene; 2021 Jul; 40(29):4746-4758. PubMed ID: 33958723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
    Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
    Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
    Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
    J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcr-TMP, a Novel Nanomolar-Active Compound That Exhibits Both MYB- and Microtubule-Inhibitory Activity.
    Yusenko MV; Biyanee A; Frank D; Köhler LHF; Andersson MK; Khandanpour C; Schobert R; Stenman G; Biersack B; Klempnauer KH
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naphthol AS-E Phosphate Inhibits the Activity of the Transcription Factor Myb by Blocking the Interaction with the KIX Domain of the Coactivator p300.
    Uttarkar S; Dukare S; Bopp B; Goblirsch M; Jose J; Klempnauer KH
    Mol Cancer Ther; 2015 Jun; 14(6):1276-85. PubMed ID: 25740244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the MYB-inhibitory potential of the Pan-HDAC inhibitor LAQ824.
    Yusenko MV; Klempnauer KH
    BBA Adv; 2022; 2():100034. PubMed ID: 37082582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the transcription factor Myb by small-molecule inhibitors.
    Uttarkar S; Frampton J; Klempnauer KH
    Exp Hematol; 2017 Mar; 47():31-35. PubMed ID: 28017646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription Factor MYB as Therapeutic Target: Current Developments.
    Klempnauer KH
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C/EBPβ sustains the oncogenic program of AML cells by cooperating with MYB and co-activator p300 in a transcriptional module.
    Klempnauer KH
    Exp Hematol; 2022 Apr; 108():8-15. PubMed ID: 35032593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module.
    Schmidt TJ; Klempnauer KH
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.
    Takao S; Forbes L; Uni M; Cheng S; Pineda JMB; Tarumoto Y; Cifani P; Minuesa G; Chen C; Kharas MG; Bradley RK; Vakoc CR; Koche RP; Kentsis A
    Elife; 2021 Feb; 10():. PubMed ID: 33527899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity.
    Yusenko M; Jakobs A; Klempnauer KH
    Sci Rep; 2018 Sep; 8(1):13159. PubMed ID: 30177851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma.
    Jiang Y; Gao R; Cao C; Forbes L; Li J; Freeberg S; Fredenburg KM; Justice JM; Silver NL; Wu L; Varma S; West R; Licht JD; Zajac-Kaye M; Kentsis A; Kaye FJ
    Oral Oncol; 2019 Nov; 98():147-155. PubMed ID: 31606723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of MiR-96 on Cell Invasion and Apoptosis in Pediatric Acute Myeloid Leukemia via Regulating MYB].
    Wang XL; Wang WF; Hao JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Apr; 29(2):439-444. PubMed ID: 33812412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.